Capricor Therapeutics (CAPR)

Capricor Therapeutics (CAPR) Balance Sheet


Capricor Therapeutics Balance Sheet

Capricor Therapeutics's total assets for Q1 2023 were $53.86M, an increase of 7.52% from the previous quarter. CAPR total liabilities were $47.66M for the fiscal quarter, a 24.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 50.09M$ 41.33M$ 34.62M$ 11.11M$ 9.25M
Total Liabilities
$ 38.31M$ 9.96M$ 6.42M$ 4.27M$ 4.63M
Total Equity Gross Minority
$ 11.79M$ 31.37M$ 28.20M$ 6.84M$ 4.62M
Total Capitalization
$ 15.16M$ 31.37M$ 28.27M$ 6.84M$ 4.62M
Preferred Stock Equity
Capital Lease Obligations
-$ 2.87M$ 0.00--
Currency in USD

Capricor Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis